Drug
Antithrombin Iii
Antithrombin Iii: highest development phase Phase 2, developed by Grifols. 2 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Grifols
Trials
| Drug | Phase | Indication |
|---|---|---|
| Antithrombin III NCT04899232 | Phase 2 | Antithrombin III Deficiency |
| Antithrombin III NCT00823082 | Phase 2 | Acquired Antithrombin III Deficiency |
Latest
No recent events.
Follow Antithrombin Iii on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.